Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

C4 Therapeutics (CCCC) Shares Issued: 2019-2024

Historic Shares Issued for C4 Therapeutics (CCCC) over the last 6 years, with Dec 2024 value amounting to $778,000.

  • C4 Therapeutics' Shares Issued rose 723.08% to $107,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $366,000, marking a year-over-year decrease of 45.29%. This contributed to the annual value of $778,000 for FY2024, which is 1241.38% up from last year.
  • According to the latest figures from FY2024, C4 Therapeutics' Shares Issued is $778,000, which was up 1,241.38% from $58,000 recorded in FY2023.
  • C4 Therapeutics' Shares Issued's 5-year high stood at $195.1 million during FY2020, with a 5-year trough of $58,000 in FY2023.
  • Its 3-year average for Shares Issued is $537,667, with a median of $777,000 in 2022.
  • In the last 5 years, C4 Therapeutics' Shares Issued soared by 71,094.89% in 2020 and then slumped by 98.81% in 2021.
  • C4 Therapeutics' Shares Issued (Yearly) stood at $195.1 million in 2020, then tumbled by 98.81% to $2.3 million in 2021, then slumped by 66.65% to $777,000 in 2022, then tumbled by 92.54% to $58,000 in 2023, then spiked by 1,241.38% to $778,000 in 2024.